DaVinci Registry(Distinctly Assess Vision in Coronary Intervention)
NCT ID: NCT00243438
Last Updated: 2009-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1300 participants
OBSERVATIONAL
2003-07-31
2005-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vision II: Evaluation of GALILEO Intravascular Radiotherapy System
NCT00180583
Sentinel Low Risk Registry
NCT04131127
Driveline Silicone Skin Interface Registry
NCT01577433
CO2-Angiography-Study to Evaluate Diagnostic and Safety to Patients With Peripher Arterial Stenotic or Occlusive Disease.
NCT05590182
Large Diameter Advanta™ V12 Covered Stent Trial for Coarctation of the Aorta
NCT00978952
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Patients who have received a Vision stent and who have diabetes and/or complex lesions.
Multilink Vision™ Stent (CE-labeled)
Patients who have diabetes and/or complex lesions and who have had a Multilink Vision™ Stent placed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multilink Vision™ Stent (CE-labeled)
Patients who have diabetes and/or complex lesions and who have had a Multilink Vision™ Stent placed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abbott Vascular
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian Hamm, MD
Role: PRINCIPAL_INVESTIGATOR
Kerckhoff-Klinik/ Benekestr. 2-8/ 61231 Bad Nauheim
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kerckhoff-Klinik
Bad Nauheim, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Version vom 18.7.2003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.